These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23718705)

  • 1. Triangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapse.
    Macareo L; Lwin KM; Cheah PY; Yuentrakul P; Miller RS; Nosten F
    Malar J; 2013 May; 12():173. PubMed ID: 23718705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances.
    Deye GA; Gettayacamin M; Hansukjariya P; Im-erbsin R; Sattabongkot J; Rothstein Y; Macareo L; Fracisco S; Bennett K; Magill AJ; Ohrt C
    Am J Trop Med Hyg; 2012 Jun; 86(6):931-5. PubMed ID: 22665596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
    Gogtay N; Kannan S; Thatte UM; Olliaro PL; Sinclair D
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008492. PubMed ID: 24163021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.
    Takeuchi R; Lawpoolsri S; Imwong M; Kobayashi J; Kaewkungwal J; Pukrittayakamee S; Puangsa-art S; Thanyavanich N; Maneeboonyang W; Day NP; Singhasivanon P
    Malar J; 2010 Nov; 9():308. PubMed ID: 21040545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
    Chu CS; Phyo AP; Lwin KM; Win HH; San T; Aung AA; Raksapraidee R; Carrara VI; Bancone G; Watson J; Moore KA; Wiladphaingern J; Proux S; Sriprawat K; Winterberg M; Cheah PY; Chue AL; Tarning J; Imwong M; Nosten F; White NJ
    Clin Infect Dis; 2018 Oct; 67(10):1543-1549. PubMed ID: 29889239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: A prospective open-label efficacy trial.
    Xu S; Zeng W; Ngassa Mbenda HG; Liu H; Chen X; Xiang Z; Li C; Zhang Y; Baird JK; Yang Z; Cui L
    Travel Med Infect Dis; 2020; 36():101499. PubMed ID: 31604130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.
    Hwang J; Alemayehu BH; Reithinger R; Tekleyohannes SG; Takele Teshi ; Birhanu SG; Demeke L; Hoos D; Melaku Z; Kassa M; Jima D; Malone JL; Nettey H; Green M; Poe A; Akinyi S; Udhayakumar V; Kachur SP; Filler S
    PLoS One; 2013; 8(5):e63433. PubMed ID: 23717423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
    Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010.
    Congpuon K; Satimai W; Sujariyakul A; Intanakom S; Harnpitakpong W; Pranuth Y; Cholpol S; Bualombai P
    J Vector Borne Dis; 2011 Dec; 48(4):190-6. PubMed ID: 22297279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
    Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
    N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of vivax malaria on the western border of Thailand.
    Luxemburger C; van Vugt M; Jonathan S; McGready R; Looareesuwan S; White NJ; Nosten F
    Trans R Soc Trop Med Hyg; 1999; 93(4):433-8. PubMed ID: 10674098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.
    Muhamad P; Ruengweerayut R; Chacharoenkul W; Rungsihirunrat K; Na-Bangchang K
    Malar J; 2011 Feb; 10():44. PubMed ID: 21324161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
    Milligan R; Daher A; Graves PM
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
    Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
    Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primaquine for preventing relapses in people with Plasmodium vivax malaria.
    Galappaththy GN; Omari AA; Tharyan P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD004389. PubMed ID: 17253504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
    Abreha T; Hwang J; Thriemer K; Tadesse Y; Girma S; Melaku Z; Assef A; Kassa M; Chatfield MD; Landman KZ; Chenet SM; Lucchi NW; Udhayakumar V; Zhou Z; Shi YP; Kachur SP; Jima D; Kebede A; Solomon H; Mekasha A; Alemayehu BH; Malone JL; Dissanayake G; Teka H; Auburn S; von Seidlein L; Price RN
    PLoS Med; 2017 May; 14(5):e1002299. PubMed ID: 28510573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.